Cargando…
Benzenesulfonamide Analogs: Synthesis, Anti-GBM Activity and Pharmacoprofiling
The tropomyosin receptor kinase A (TrkA) family of receptor tyrosine kinases (RTKs) emerge as a potential target for glioblastoma (GBM) treatment. Benzenesulfonamide analogs were identified as kinase inhibitors possessing promising anticancer properties. In the present work, four known and two novel...
Autores principales: | Murugesan, Akshaya, Konda Mani, Saravanan, Thiyagarajan, Ramesh, Palanivel, Suresh, Gurbanov, Atash V., Zubkov, Fedor I., Kandhavelu, Meenakshisundaram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418358/ https://www.ncbi.nlm.nih.gov/pubmed/37569654 http://dx.doi.org/10.3390/ijms241512276 |
Ejemplares similares
-
Methanodibenzo[b,f][1,5]dioxocins as Novel Glutaminase Inhibitor with Anti-Glioblastoma Potential
por: Murugesan, Akshaya, et al.
Publicado: (2023) -
Identifying the miRNA Signature Association with Aging-Related Senescence in Glioblastoma
por: Gnanavel, Mutharasu, et al.
Publicado: (2021) -
Anticancer activity of THMPP: Downregulation of PI3K/ S6K1 in breast cancer cell line
por: Palanivel, Suresh, et al.
Publicado: (2020) -
Synthesis and Preclinical
Validation of Novel Indole
Derivatives as a GPR17 Agonist for Glioblastoma Treatment
por: Nguyen, Phung, et al.
Publicado: (2021) -
Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent
por: Le, Hien Thi Thu, et al.
Publicado: (2019)